Generic name: brigatinib [ bri-GAT-i-nib ]
Brand name: Alunbrig
Dosage form: oral tablet (180 mg; 30 mg; 90 mg; 90 mg-180 mg)
Drug class: Multikinase inhibitors
What is brigatinib?
Brigatinib is used to treat non-small cell lung cancer that has spread to other parts of the body (metastatic) after other treatments have failed.
Brigatinib is used only if your cancer has a specific genetic marker (an abnormal "ALK" gene). Your doctor will test you for this gene.
Brigatinib may also be used for purposes not listed in this medication guide.
Brigatinib can cause serious side effects such as lung problems, vision problems, high blood pressure, high blood sugar, very slow heartbeats, muscle damage, or pancreatitis.
Call your doctor at once if you have side effects, such as: severe headache, confusion, feeling light-headed, blurred vision, seeing flashes of light or "floaters" in your vision, increased thirst or urination, hunger, nausea, upper stomach pain spreading to your back, unexplained muscle pain or weakness, fever, cough, chest pain, trouble breathing, very slow heartbeats, or feeling like you might pass out.
Before taking this medicine
You should not use brigatinib if you are allergic to it.
Tell your doctor if you have ever had:
lung disease or breathing problems;
high blood pressure;
diabetes or glucose intolerance;
liver disease; or
kidney disease (or if you are on dialysis).
You may need to have a negative pregnancy test before starting this treatment.
Brigatinib can harm an unborn baby if the mother or the father is using brigatinib.
If you are a woman, do not use this medicine if you are pregnant. Brigatinib can make hormonal birth control less effective, including birth control pills, injections, implants, skin patches, and vaginal rings. Use an effective non-hormonal form of birth control such as an intrauterine device (IUD). Avoid getting pregnant for at least 4 months after your last dose.
If you are a man, use condoms or other barrier birth control if your sex partner is able to get pregnant. Keep using condoms for at least 3 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using brigatinib.
This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because brigatinib can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
How should I take brigatinib?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.
Brigatinib is usually taken once per day, with or without food.
Swallow the tablet whole and do not crush, chew, or break it.
If you vomit shortly after taking brigatinib, do not take another dose. Stay on your regular schedule.
Your blood pressure will need to be checked often.
You should not stop using brigatinib unless your doctor tells you to.
Store at room temperature away from moisture and heat.
What happens if I miss a dose?
Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking brigatinib?
Grapefruit may interact with brigatinib and lead to unwanted side effects. Avoid the use of grapefruit products.
brigatinib may cause blurred vision and may impair your reactions. Avoid driving or hazardous activity until you know how this medicine will affect you.
Brigatinib side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Brigatinib may cause serious side effects. Call your doctor at once if you have:
lung problems--cough, trouble breathing, chest pain, fever;
vision problems--blurred vision, double vision, increased sensitivity to light, seeing flashes of light or "floaters" in your vision;
high blood pressure--severe headache, pounding in your neck or ears, dizziness;
high blood sugar--increased thirst, increased urination, hunger, nausea, fruity breath odor, weakness, confusion;
heart problems--very slow heartbeats, feeling like you might pass out;
muscle problems--unexplained muscle pain or weakness; or
pancreatitis--upper stomach pain (worse with eating and may spread to your back), nausea, weight loss.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of brigatinib may include:
increased blood pressure;
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Brigatinib dosing information
Usual Adult Dose for Non-Small Cell Lung Cancer:
Initial dose: 90 mg orally once a day for the first 7 days
Maintenance dose: 180 mg orally once a day
-Patients should be selected for the treatment of metastatic NSCLC based on the presence of ALK positivity in tumor specimens.
-FDA-approved test for the detection of ALK rearrangements in NSCLC is available at http://www.fda.gov/CompanionDiagnostic
-Treatment should be continued until disease progression or unacceptable toxicity.
Use: For treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test
What other drugs will affect brigatinib?
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Many drugs can affect brigatinib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.
Is Alunbrig the same as brigatinib?
Yes, Alunbrig is the brand name product for brigatinib, a medicine used to treat non-small cell lung cancer that has spread in the body. Alunbrig, from Takeda Pharmaceuticals, was first approved in April 2017. There is no generic alternative for Alunbrig at this time.
More about brigatinib
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- En español
Related treatment guides
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2023 Cerner Multum, Inc. Version: 3.01.